Annual Shareholders Equity
-$47.45 M
+$38.30 M+44.67%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual stockholders equity is -$47.45 million, with the most recent change of +$38.30 million (+44.67%) on December 31, 2023.
- During the last 3 years, CTMX annual shareholders equity has fallen by -$39.67 million (-510.33%).
- CTMX annual shareholders equity is now -136.25% below its all-time high of $130.88 million, reached on December 31, 2018.
Performance
CTMX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$23.45 M
+$7.78 M+24.90%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly stockholders equity is -$23.45 million, with the most recent change of +$7.78 million (+24.90%) on September 30, 2024.
- Over the past year, CTMX quarterly shareholders equity has increased by +$27.79 million (+54.23%).
- CTMX quarterly shareholders equity is now -114.87% below its all-time high of $157.66 million, reached on September 30, 2018.
Performance
CTMX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CTMX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.7% | +54.2% |
| 3 y3 years | -510.3% | +54.2% |
| 5 y5 years | -136.3% | +54.2% |
CTMX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | +44.7% | -134.4% | +72.9% |
| 5 y | 5-year | -192.8% | +44.7% | -116.1% | +72.9% |
| alltime | all time | -136.3% | +44.7% | -114.9% | +77.9% |
CytomX Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$23.45 M(-24.9%) |
| Jun 2024 | - | -$31.23 M(-1.4%) |
| Mar 2024 | - | -$31.68 M(-33.2%) |
| Dec 2023 | -$47.45 M(-44.7%) | -$47.45 M(-7.4%) |
| Sep 2023 | - | -$51.24 M(-39.7%) |
| Jun 2023 | - | -$85.03 M(-1.9%) |
| Mar 2023 | - | -$86.64 M(+1.0%) |
| Dec 2022 | -$85.75 M(>+9900.0%) | -$85.75 M(-401.2%) |
| Sep 2022 | - | $28.47 M(-41.5%) |
| Jun 2022 | - | $48.71 M(-28.6%) |
| Mar 2022 | - | $68.19 M(<-9900.0%) |
| Dec 2021 | -$459.00 K(-94.1%) | -$459.00 K(-100.4%) |
| Sep 2021 | - | $111.67 M(-14.7%) |
| Jun 2021 | - | $130.95 M(-10.3%) |
| Mar 2021 | - | $146.02 M(-1978.3%) |
| Dec 2020 | -$7.77 M(-115.2%) | -$7.77 M(-116.2%) |
| Sep 2020 | - | $48.06 M(-18.3%) |
| Jun 2020 | - | $58.83 M(-15.7%) |
| Mar 2020 | - | $69.77 M(+36.5%) |
| Dec 2019 | $51.11 M | $51.11 M(-37.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $82.11 M(-19.1%) |
| Jun 2019 | - | $101.50 M(-17.2%) |
| Mar 2019 | - | $122.57 M(-6.4%) |
| Dec 2018 | $130.88 M(+87.3%) | $130.88 M(-17.0%) |
| Sep 2018 | - | $157.66 M(+283.3%) |
| Jun 2018 | - | $41.13 M(-17.1%) |
| Mar 2018 | - | $49.65 M(-29.0%) |
| Dec 2017 | $69.90 M(-10.9%) | $69.90 M(+53.7%) |
| Sep 2017 | - | $45.48 M(-12.9%) |
| Jun 2017 | - | $52.24 M(-29.2%) |
| Mar 2017 | - | $73.79 M(-6.0%) |
| Dec 2016 | $78.48 M(-37.7%) | $78.48 M(-12.2%) |
| Sep 2016 | - | $89.42 M(-11.6%) |
| Jun 2016 | - | $101.19 M(-10.2%) |
| Mar 2016 | - | $112.71 M(-10.6%) |
| Dec 2015 | $126.07 M(-260.5%) | $126.07 M(-218.9%) |
| Sep 2015 | - | -$106.05 M(-266.7%) |
| Jun 2015 | - | $63.60 M(-181.0%) |
| Dec 2014 | -$78.54 M(+77.4%) | -$78.54 M |
| Dec 2013 | -$44.28 M | - |
FAQ
- What is CytomX Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for CytomX Therapeutics?
- What is CytomX Therapeutics annual shareholders equity year-on-year change?
- What is CytomX Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly shareholders equity year-on-year change?
What is CytomX Therapeutics annual stockholders equity?
The current annual shareholders equity of CTMX is -$47.45 M
What is the all time high annual shareholders equity for CytomX Therapeutics?
CytomX Therapeutics all-time high annual stockholders equity is $130.88 M
What is CytomX Therapeutics annual shareholders equity year-on-year change?
Over the past year, CTMX annual stockholders equity has changed by +$38.30 M (+44.67%)
What is CytomX Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CTMX is -$23.45 M
What is the all time high quarterly shareholders equity for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly stockholders equity is $157.66 M
What is CytomX Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CTMX quarterly stockholders equity has changed by +$27.79 M (+54.23%)